OXY OVERNIGHT ACNE REDUCING PATCHES- salicylic acid patch 
The Mentholatum Company

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active ingredient

Salicylic acid 0.5%

Purpose

Salicylic acid - Acne treatment

Uses

treats and helps prevent acne

Warnings

For external use only

When using this product

  • keep away from eyes, lips and mouth. If contact occurs, flush thoroughly with water.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

If pregnant or breast-feeding

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive ingredients

acrylates/ethylhexyl acrylate copolymer, water, nonoxynol-30, alcohol denatured, butylene glycol, C13-14 isoparaffin, epilobium angustifolium flower/leaf/stem extract, kaolin, laureth-7, melaleuca alternifolia (tea tree) leaf oil, phenoxyethanol, phytosphingosine, polysorbate 80, PVP, sodium hyaluronate, sodium hydroxide, sodium metabisulfite, sodium polyacrylate, vitis vinifera (grape) seed extract, volcanic ash

Questions?

1-877-636-2677 MON-FRI 9 AM - 5 PM (EST)

Principal Display Panel

Oxy Overnight Acne Reducing Patches

Principal Display Panel

Drug Facts
OXY OVERNIGHT ACNE REDUCING PATCHES 
salicylic acid patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10742-8177
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID5 mg
Inactive Ingredients
Ingredient NameStrength
2-ETHYLHEXYL ACRYLATE (UNII: HR49R9S6XG)  
WATER (UNII: 059QF0KO0R)  
NONOXYNOL-30 (UNII: JJX07DG188)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
C13-14 ISOPARAFFIN (UNII: E4F12ROE70)  
EPILOBIUM ANGUSTIFOLIUM WHOLE (UNII: C278QS9YBT)  
KAOLIN (UNII: 24H4NWX5CO)  
LAURETH-7 (UNII: Z95S6G8201)  
TEA TREE OIL (UNII: VIF565UC2G)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
SODIUM POLYACRYLATE (8000 MW) (UNII: 285CYO341L)  
VITIS VINIFERA SEED (UNII: C34U15ICXA)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10742-8177-130 in 1 PACKAGE; Type 0: Not a Combination Product01/01/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D01/01/2018
Labeler - The Mentholatum Company (002105757)
Registrant - The Mentholatum Company (002105757)
Establishment
NameAddressID/FEIBusiness Operations
The Mentholatum Company002105757manufacture(10742-8177)

Revised: 2/2023
Document Id: f42015a8-4f35-2147-e053-2a95a90a4f2f
Set id: d9652f3f-bb6e-4d74-88d6-d4dbaa3de22d
Version: 7
Effective Time: 20230207
 
The Mentholatum Company